[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356393-105":59,"doc-detail-356393-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-microenvironment-transcriptional-activity-enables-robust-stratification-of-chemotherapy-response-in-triple-negative-breast-cancer","Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer","","Triple-negative breast cancer shows heterogeneous treatment responses, and predefined pathway-based molecular subtypes provide limited prognostic value. The study introduces tumor-specific total mRNA expression (TmS), a pathway-agnostic deconvolution metric derived from matched RNA/DNA sequencing. Across 575 TNBC patients spanning Western and East Asian populations, TmS outperforms established subtypes in predicting chemotherapy outcomes. Stromal enrichment with immune exclusion marks chemotherapy-resistant low-TmS tumors, while extracellular matrix organization reveals a conserved therapeutic vulnerability.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-microenvironment-transcriptional-activity-enables-robust-stratification-of-chemotherapy-response-in-triple-negative-breast-cancer/356393/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-microenvironment-transcriptional-activity-enables-robust-stratification-of-chemotherapy-response-in-triple-negative-breast-cancer/356393.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What metric does the study introduce to stratify triple-negative breast cancer chemotherapy response?","Question",{"text":112,"@type":113},"It introduces tumor-specific total mRNA expression (TmS), a pathway-agnostic deconvolution metric derived from matched RNA/DNA sequencing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TmS compare with existing TNBC molecular subtypes?",{"text":117,"@type":113},"TmS subtypes outperform established TNBC subtypes in predicting chemotherapy response across diverse populations.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological programs are associated with chemotherapy-resistant low-TmS tumors?",{"text":121,"@type":113},"Stromal enrichment with immune exclusion defines treatment-resistant low-TmS tumors as a universal feature across cohorts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356393,1790379291,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nTumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer  \nGraphical abstract Authors  \nYaoyi Dai, Xiaoxi Pan, Shuai Guo, ..., Bora Lim, Yinyin Yuan, Wenyi Wang  \nCorrespondence  \n[wwang7@mdanderson.org](wwang7@mdanderson.org)  \nIn brief  \nDai et al. demonstrate that tumor-specific total mRNA expression (TmS) outperforms existing classifications in stratifying triple-negative breast cancer chemotherapy responses across diverse populations. This deconvolution approach reveals population-specific tumor microenvironment programs and identifies extracellular matrix targeting asa therapeutic strategy for patients with low-TmS.  \nHighlights  \n• TmS subtypes outperform existing TNBC subtypes in predicting chemotherapy response  \n• Stromal barriers and immune exclusion define treatmentresistant low-TmS tumors  \n• Population-specific immune patterns distinguish Asian and European low-TmS tumors  \n• ECM signatures represent conserved therapeutic targets across all populations  \nDai et al., 2026, Cell Reports Medicine 7, 102610  \nFebruary 17, 2026 © 2026 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2026.102610](https://doi.org/10.1016/j.xcrm.2026.102610)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nTumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer  \nYaoyi Dai,1,2 Xiaoxi Pan,3,4 Shuai Guo,1 Shuangxi Ji,1 Shaolong Cao,1,16 Matthew D. Montierth,1,2 Yujie Jiang,1,17 Jeffrey T. Chang,5 Leming Shi,6 Shabnam Shalapour,7 Gloria V. Echeverria,8,9,10,11 Lucy Yates,12 Johan Staaf,13 Bora Lim,14,15 Yinyin Yuan,3,4 and Wenyi Wang1,18,*  \n1Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n2Graduate Program of Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX 77030, USA  \n3Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n4Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n5McGovern Medical School, Houston, TX 77030, USA  \n6State Key Laboratory of Genetic Engineering, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai 200093, China  \n7Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n8Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA  \n9Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA  \n10Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA  \n11Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA  \n12Wellcome Sanger Institute, Hinxton CB10 1SA, UK  \n13Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, 223 81 Lund, Sweden  \n14Department of Breast Medical Oncology, The Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n15The Morgan Welch IBC Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n16Present address: Biogen Inc. , Cambridge, MA 02142, USA  \n17Present address: AbbVie Inc. , North Chicago, IL 60064, USA  \n18Lead contact  \n*[Correspondence:](Correspondence: wwang7@mdanderson.org)[ wwang7@mdanderson.org](Correspondence: wwang7@mdanderson.org)  \n[https://doi.org/10.1016/j.xcrm.2026.102610](https://doi.org/10.1016/j.xcrm.2026.102610)  \nSUMMARY  \nTriple-negative breast cancer (TNBC) exhibits heterogeneous treatment responses, yet molecular subtypes based on predefined biological pathways show limited prognostic value. We introduce tumor-specific total mRNA expression (TmS), a pathway-agnostic deconvolution metric derived from","cbCaihVCV5eX8nu3","https://ap.wps.com/l/cbCaihVCV5eX8nu3","pdf",9686513,22,"English","# Summary\n# Highlights\n# Summary\n# Introduction","[{\"question\":\"What metric does the study introduce to stratify triple-negative breast cancer chemotherapy response?\",\"answer\":\"It introduces tumor-specific total mRNA expression (TmS), a pathway-agnostic deconvolution metric derived from matched RNA/DNA sequencing.\"},{\"question\":\"How does TmS compare with existing TNBC molecular subtypes?\",\"answer\":\"TmS subtypes outperform established TNBC subtypes in predicting chemotherapy response across diverse populations.\"},{\"question\":\"What biological programs are associated with chemotherapy-resistant low-TmS tumors?\",\"answer\":\"Stromal enrichment with immune exclusion defines treatment-resistant low-TmS tumors as a universal feature across cohorts.\"}]","Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer | PDF",1790125157,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2423f4953232e66a641c5b1d58cb3853.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23337efea3753b6e2ddf040287787bf5.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b2530a112c9a8b1d8c5ad250adc2a6b.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63684dce652054a65a2defb131b44c8c.webp",980,1272]